17Feb 2023
N4-acetylcytidine modification of lncRNA CTC-490G23.2 promotes cancer metastasis through interacting with PTBP1 to increase CD44 alternative splicing

N4-acetylcytidine modification of lncRNA CTC-490G23.2 promotes cancer metastasis through interacting with PTBP1 to increase CD44 alternative splicing

The study reveals that N4-acetylcytidine (ac4C) modification exists in long noncoding RNAs (lncRNAs) and is responsible for the stabilization and overexpression of lncRNA CTC-490G23.2 in primary esophageal squamous cell carcinoma (ESCC). CTC-490G23.2 acts as a scaffold to increase the binding of CD44 pre-mRNA to polypyrimidine tract-binding protein 1 (PTBP1), leading to a switch from the standard isoform CD44s to the variant isoform CD44v(8-10). CD44v(8-10) binds to and increases the protein stability of vimentin, promoting cancer invasion and metastasis in vitro and in vivo. The study suggests that targeting CTC490G23.2 may be a potential therapeutic strategy for cancer metastasis.

  • #oncology

Like

Save

Share